1.59
price down icon0.63%   -0.01
after-market アフターアワーズ: 1.59
loading

MAIA Biotechnology Inc (MAIA) 最新ニュース

pulisher
Apr 01, 2025

MAIA Biotechnology- Phase 2 Trial Thio-101 Expansion Underway Potential Filing In 2026 For Accelerated Approval - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

MAIA Biotechnology targets 2026 for FDA approval of cancer drug - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders - Yahoo Finance

Apr 01, 2025
pulisher
Mar 29, 2025

MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know - MSN

Mar 29, 2025
pulisher
Mar 28, 2025

Is MAIA Biotechnology, Inc. (MAIA)he Cheapest Stock Insiders Are Buying In March? - Insider Monkey

Mar 28, 2025
pulisher
Mar 28, 2025

MAIA Biotechnology Showcases THIO-101 Trial at ELCC 2025 - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Q1 EPS Forecast for MAIA Biotechnology Lifted by Analyst - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

MAIA Biotechnology revises offering to $11.2 million By Investing.com - Investing.com Australia

Mar 27, 2025
pulisher
Mar 27, 2025

Diamond Equity Comments on MAIA Biotechnology Q1 Earnings - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

MAIA Biotechnology revises offering to $11.2 million - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Maia Biotechnology IncDecreases Maximum Aggregate Offering Price To $11.2 MillionSEC Filing - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

MAIA Biotechnology publishes preclinical data for telomere-targeting THIO dimer - MSN

Mar 26, 2025
pulisher
Mar 25, 2025

15 Cheapest Stocks Insiders Are Buying In March - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025 - BioSpace

Mar 25, 2025
pulisher
Mar 25, 2025

Breakthrough Lung Cancer Drug Shows Exceptional Phase 2 Results: Key Biomarker Discovery - Stock Titan

Mar 25, 2025
pulisher
Mar 21, 2025

Maia Bio touts two advances for its lead cancer drug in development - Crain's Chicago Business

Mar 21, 2025
pulisher
Mar 20, 2025

MAIA Biotechnology reports breakthrough in cancer treatment research By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

MAIA Biotechnology advances with new drug name approval By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug - BioSpace

Mar 20, 2025
pulisher
Mar 20, 2025

MAIA Biotechnology reports breakthrough in cancer treatment research - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Groundbreaking Cancer Drug Breakthrough: THIO Compound Tackles Drug Resistance Head-On - Stock Titan

Mar 20, 2025
pulisher
Mar 20, 2025

MAIA Biotechnology Receives USAN Council Approval for “Ateganosine” as Nonproprietary Name for Anticancer Agent THIO - BioSpace

Mar 20, 2025
pulisher
Mar 19, 2025

Maia Biotechnology Receives Usan Council Approval For "Ateganosine" As Nonproprietary Name For Anticancer Agent Thio - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

MAIA Biotechnology advances with new drug name approval - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

MAIA Biotechnology receives USAN Council approval for ‘Ateganosine’ name - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

MAIA Biotechnology, Inc. Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Major Milestone: MAIA's Novel Lung Cancer Drug Gets Official Name Ateganosine - Stock Titan

Mar 19, 2025
pulisher
Mar 13, 2025

MAIA Biotechnology (MAIA) Expected to Announce Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 05, 2025

Maia Biotechnology director Guerrero Ramiro buys $49,999 in stock - Investing.com

Mar 05, 2025
pulisher
Feb 27, 2025

MAIA Biotechnology, Inc. to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Maia Biotechnology Plans to Begin Phase 3 Lung Cancer Trial of THIO-104 in H2 -February 27, 2025 at 10:58 am EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

MAIA Biotechnology to initiate THIO-104 trial - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Can MAIA's THIO Outperform Chemotherapy in Advanced Lung Cancer? Phase 3 Trial Will Decide - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients - Business Wire

Feb 27, 2025
pulisher
Feb 27, 2025

MAIA Biotechnology Secures $1.43 Million in Non-Brokered Private Placement - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

MAIA Biotechnology announces non-brokered private placement of $1.43M - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

MAIA Biotech announces trial design to expand THIO-101 Phase 2 NSCLC study - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

MAIAMAIA Biotechnology Inc. Latest Stock News & Market Updates - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

MAIA Biotechnology expands phase 2 cancer trial - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer - Yahoo Finance

Feb 26, 2025
pulisher
Feb 25, 2025

Maia Biotechnology director Stan Smith acquires $75,000 in stock - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Maia Biotechnology director Stan Smith acquires $75,000 in stock By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million - BioSpace

Feb 25, 2025
pulisher
Feb 24, 2025

Can This $4.1M Funding Push MAIA's Cancer Drug Trial to the Next Level? - Stock Titan

Feb 24, 2025
pulisher
Feb 20, 2025

MAIA Biotechnology announces $2.7M private placement - MSN

Feb 20, 2025
pulisher
Feb 19, 2025

MAIA Biotechnology, Inc. announced that it expects to receive $2.715 million in funding -February 17, 2025 - Marketscreener.com

Feb 19, 2025
pulisher
Feb 18, 2025

MAIA Biotechnology Announces Private Placement of $2,715,000 - BioSpace

Feb 18, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
大文字化:     |  ボリューム (24 時間):